Anoro Ellipta

GlaxoSmithKline LLC🇺🇸 United States

FDA Page

Effective Date: Jun 2, 2023
Approval ID: 2dbd0671-c565-40c5-bf0f-e324db26799c
Products: 0 registered
Version: 27

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"br": [null, null, null], "#text": "These highlights do not include all the information needed to use ANORO ELLIPTA safely and effectively. See full prescribing information for ANORO ELLIPTA.\n ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder), for oral inhalation useInitial U.S. Approval: 2013"}

Quick Stats

Total Products0

Labelers1

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.